INTRODUCTION
A subpopulation of human bone marrow-derived (B) lymphocytes stimulates the proliferation of autologous thymus-derived (T) lymphocytes (1, 2) . This autologous mixed lymphocyte reaction (MLR)' has two cardinal characteristics of an immune response: immunological memory and specificity (3) . The autologous MLR has been shown to provide a proliferative stimulus required for the generation of cytotoxic lymphocytes (4) , and preliminary evidence suggests that suppressor actixity is generated during this reaction (unpublished observation).
Recently, Sakane et al. (5) reported that lymphocytes from patients with systemic lupus erythematosus (SLE) fail to express an autologous MLR. These authors offered circumstantial evidence that defective T-cell function leads to the impaired autologous MLR. We also had found that the autologous MLR is depressed in patients with SLE (6) . We now present evidence that this defect results from a change in the B-cell preparations from patients with SLE. This conclusion was based upon data obtained from three pairs of MLRidentical siblings discordant for SLE. Received for publication 25 September 1978 and in revised form 3 November 1978.
1 Abbreviations used in this paper: MLR, mixed lymphocyte reaction; SLE, systemic lupus erythematosus.
METHODS
Patients studied. 10 patients with SLE were studied. The patients were females between the ages of 19 and 43. The patients were studied when disease activity was minimal. Eight patients were untreated at the time of study; one patient was receiving 10 
RESULTS
Autologous and allogeneic MLR in SLE patients.
T lymphocytes from normnal subjects or patients with SLE were cultured with irradiated autologous or allogeneic B lymphocytes (Table I ). The autologous MLR in patients with SLE was strikingly and significantly (P < 0.003) depressed compared to the autologous MLR in normal subjects. This was not attributable to differences in the background incorporation of thymidine by T lymphocytes. The ir..paired autologous MLR was not related to duration of disease or steroid therapy. In contrast to the depressed autologous MLR, (9, 10) . The failure of patients with SLE to express suppressor activity may be a consequence of their impaired autologous MLR.
